Clinical Trials in Montbéliard, France
10 recruiting
Showing 1–10 of 10 trials
Recruiting
Phase 2
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Centre Hospitalier Universitaire de Besancon105 enrolled14 locationsNCT05528952
Recruiting
Not Applicable
Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening
Colorectal, Cancer
Centre Hospitalier Universitaire de Besancon400 enrolled3 locationsNCT04767568
Recruiting
Phase 3
Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
Anal Cancer
Federation Francophone de Cancerologie Digestive310 enrolled114 locationsNCT06207981
Recruiting
Phase 2
Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
Colorectal, CancerDigestive Cancer
UNICANCER400 enrolled34 locationsNCT06475352
Recruiting
Not Applicable
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
Lung CancerHead and Neck Cancer
Centre Hospitalier Universitaire de Besancon220 enrolled4 locationsNCT03117946
Recruiting
Phase 2Phase 3
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon446 enrolled16 locationsNCT05462613
Recruiting
Phase 2
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon174 enrolled10 locationsNCT06425133
Recruiting
Phase 3
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
Squamous Cell Carcinoma of Head and Neck
UNICANCER102 enrolled26 locationsNCT04747054
Recruiting
Phase 2
Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer
Gastroesophageal Junction AdenocarcinomaGastric AdenocarcinomaEsophagus Adenocarcinoma
UNICANCER118 enrolled29 locationsNCT05476796
Recruiting
Phase 2
Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
Squamous Cell Anal CarcinomaMetastatic Squamous Cell Carcinoma
Centre Hospitalier Universitaire de Besancon34 enrolled5 locationsNCT04894370